Safety, pharmacokinetics (PK), pharmacodynamics (PD), and clinical activity of the oral AKT inhibitor GSK2141795 (GSK795) in a phase I first-in-human study Meeting Abstract


Authors: Burris, H. A.; Siu, L. L.; Infante, J. R.; Wheler, J. J.; Kurkjian, C.; Opalinska, J.; Smith, D. A.; Antal, J. M.; Gauvin, J. L.; Gonzalez, T.; Adams, L. M.; Bedard, P.; Gerecitano, J. F.; Kurzrock, R.; Moore, K. N.; Morris, S. R.; Aghajanian, C.
Abstract Title: Safety, pharmacokinetics (PK), pharmacodynamics (PD), and clinical activity of the oral AKT inhibitor GSK2141795 (GSK795) in a phase I first-in-human study
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880301433
PROVIDER: wos
DOI: 10.1200/jco.2011.29.15_suppl.3003
Notes: Meeting Abstract: 3003 -- Source: Wos
Altmetric Score
MSK Authors